These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 8784659

  • 41. Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.
    Dominguez RA.
    J Clin Psychiatry; 1992 Oct; 53 Suppl():56-9. PubMed ID: 1429485
    [Abstract] [Full Text] [Related]

  • 42. Sertraline in the treatment of obsessive-compulsive disorder.
    Clary CM.
    Am Fam Physician; 1999 Jan 01; 59(1):49. PubMed ID: 9917574
    [No Abstract] [Full Text] [Related]

  • 43. [Drug of the month. Sertraline (Serlain)].
    Scheen AJ.
    Rev Med Liege; 1994 Sep 01; 49(9):519-20. PubMed ID: 7939024
    [No Abstract] [Full Text] [Related]

  • 44. Treatment of premature ejaculation.
    Evanoff A, Newton WP.
    J Fam Pract; 1998 Apr 01; 46(4):280-1. PubMed ID: 9564366
    [No Abstract] [Full Text] [Related]

  • 45. Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.
    Fineberg NA, Pampaloni I, Pallanti S, Ipser J, Stein DJ.
    Int Clin Psychopharmacol; 2007 Nov 01; 22(6):313-22. PubMed ID: 17917549
    [Abstract] [Full Text] [Related]

  • 46. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
    Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowtiz MR, Lydiard B.
    Int Clin Psychopharmacol; 1995 Jun 01; 10(2):57-65. PubMed ID: 7673657
    [Abstract] [Full Text] [Related]

  • 47. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial.
    Dannon PN, Sasson Y, Hirschmann S, Iancu I, Grunhaus LJ, Zohar J.
    Eur Neuropsychopharmacol; 2000 May 01; 10(3):165-9. PubMed ID: 10793318
    [Abstract] [Full Text] [Related]

  • 48. Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs).
    Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G.
    Psychopharmacol Bull; 1996 May 01; 32(1):167-73. PubMed ID: 8927668
    [Abstract] [Full Text] [Related]

  • 49. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
    Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran LM, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K.
    Int Clin Psychopharmacol; 1997 Nov 01; 12(6):309-16. PubMed ID: 9547132
    [Abstract] [Full Text] [Related]

  • 50. The role of SSRIs in panic disorder.
    Sheehan DV, Harnett-Sheehan K.
    J Clin Psychiatry; 1996 Nov 01; 57 Suppl 10():51-8; discussion 59-60. PubMed ID: 8917132
    [Abstract] [Full Text] [Related]

  • 51. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
    Diniz JB, Shavitt RG, Fossaluza V, Koran L, Pereira CA, Miguel EC.
    J Clin Psychopharmacol; 2011 Dec 01; 31(6):763-8. PubMed ID: 22020357
    [Abstract] [Full Text] [Related]

  • 52. Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder.
    Leonard HL, Topol D, Bukstein O, Hindmarsh D, Allen AJ, Swedo SE.
    J Am Acad Child Adolesc Psychiatry; 1994 Dec 01; 33(6):792-4. PubMed ID: 8083135
    [Abstract] [Full Text] [Related]

  • 53. Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.
    Zajecka J, Mitchell S, Fawcett J.
    Psychopharmacol Bull; 1997 Dec 01; 33(4):755-60. PubMed ID: 9493488
    [Abstract] [Full Text] [Related]

  • 54. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A, Hollander E.
    Psychiatr Serv; 2003 Aug 01; 54(8):1111-8. PubMed ID: 12883138
    [Abstract] [Full Text] [Related]

  • 55. High doses of sertraline for treatment-resistant obsessive-compulsive disorder.
    Byerly MJ, Goodman WK, Christensen R.
    Am J Psychiatry; 1996 Sep 01; 153(9):1232-3. PubMed ID: 8780435
    [No Abstract] [Full Text] [Related]

  • 56. Breakthrough in psychiatric care: pharmacological treatment of obsessive-compulsive disorders with implications for nursing care.
    Giger JN, Davidhizar R, Poole VL.
    J Pract Nurs; 2002 Sep 01; 52(2):12-6; quiz 17, 21. PubMed ID: 12122747
    [No Abstract] [Full Text] [Related]

  • 57. Should young people be given antidepressants? No.
    Timimi S.
    BMJ; 2007 Oct 13; 335(7623):751. PubMed ID: 17932206
    [Abstract] [Full Text] [Related]

  • 58. Comments on "Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression".
    Anderson GM.
    J Clin Psychopharmacol; 1996 Jun 13; 16(3):256-7. PubMed ID: 8784661
    [No Abstract] [Full Text] [Related]

  • 59. [Torin (sertraline) in the treatment of depressive and obsessive-compulsive disorders in children].
    Malinina EV, Zabozlaeva IV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010 Jun 13; 110(8):22-4. PubMed ID: 20823825
    [Abstract] [Full Text] [Related]

  • 60. Sertraline and breast-feeding.
    Epperson CN, Anderson GM, McDougle CJ.
    N Engl J Med; 1997 Apr 17; 336(16):1189-90. PubMed ID: 9102576
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.